OPRK1 and schizophrenia: The effects of Dyn/KOR agonism by exogenous or endogenous agonists in animal models result in affective, motivational, and cognitive phenotypes relevant to psychiatric disorders including PTSD, depression, schizophrenia, and substance use disorder.